Dambkowski Carl sold ORKA
May 21, 2026 · Form 4 insider transaction
Dambkowski Carl sold 38,318 shares of Oruka Therapeutics, Inc. at $58.43 per share, a transaction worth $2.24M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 19, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.71 to $58.70, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.